Seattle breakthrough offers Spokane boy relief from rare hunger condition
A new FDA-approved therapy, setmelanotide, is providing relief for patients suffering from hypothalamic obesity caused by brain injury.
Velocity timeline
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
The FDA has approved a new therapy, setmelanotide, to treat obesity resulting from brain injury. A boy from Spokane has utilized this treatment to find relief from a rare condition of constant hunger caused by brain damage.
Coverage from The ASCO Post, the limbic, and NR Times emphasizes that the drug targets acquired hypothalamic obesity, specifically in patients with brain tumors. Reports from KREM and The Spokesman-Review highlight the personal impact on the Spokane patient, who is described as being able to get "back to living life.
Attention is now on trial results showing setmelanotide's ability to cut BMI in patients with hypothalamic obesity.
Synthesized by Newsylist from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 6h ago.
Quick answers
What is the name of the approved therapy?
The therapy is called setmelanotide.
What specific condition does this treatment address?
It treats hypothalamic obesity caused by brain injury or brain tumors.
What result was noted in the clinical trial?
According to the limbic, the trial showed that setmelanotide cuts BMI.
Coverage (5)
- Setmelanotide in Patients With Acquired Hypothalamic Obesity From Brain Tumors The ASCO Post · 1d ago
- ‘Back to living life’: Spokane boy finds treatment to constant hunger caused by brain damage The Spokesman-Review · 1d ago
- Setmelanotide cuts BMI in hypothalamic obesity trial the limbic · 1d ago
- FDA approves new therapy for obesity caused by brain injury NR Times · 1d ago
- Seattle breakthrough offers Spokane boy relief from rare hunger condition KREM · 1d ago broke it first
People, places & organizations
Topics
Related trends
FDA still focused on Taylor Farms lettuce as Cyclospora source despite retracted test
The FDA continues to target Taylor Farms lettuce as the source of a Cyclospora outbreak despite a retracted positive test result.
Alzheimer's: Real-world study confirms Leqembi therapy benefits
The FDA has approved a subcutaneous autoinjector for Leqembi, enabling at-home initiation doses for early Alzheimer's disease.
Explosive diarrhea outbreak: Lettuce tests positive for cyclospora, FDA says
The FDA and health officials have linked a widespread outbreak of explosive diarrhea to iceberg lettuce contaminated with the parasite cyclospora.
Cyclospora: iceberg lettuce recalled in 27 states and more products may follow
Iceberg lettuce is being recalled across 27 states following a cyclosporiasis outbreak linked to Taylor Farms.
Pillsbury recalls 2 bread products over potential glass contamination
General Mills is recalling 730,000 Pillsbury bread rolls across 18 states due to potential glass contamination.
Brain-shuttle biologics chart new paths across the blood–brain barrier
New brain-shuttle biologics are overcoming the blood-brain barrier to deliver critical treatments for Alzheimer's and cancer.